Prothena Corporation plc provided earnings guidance for the year 2024. The company expects full year 2024 net cash used in operating and investing activities to be between $208 million and $225 million. The estimated full year 2024 net cash used in operating and investing activities is primarily driven by an estimated net loss of $229 million to $255 million, which includes an estimated $51 million of noncash share-based compensation expense.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.04 USD | -0.43% | -5.10% | -42.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.10% | 1.14B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Corporation plc Provides Earnings Guidance for the Year 2024